Grand Pharmaceutical Group Limited (HKG:0512)

Market Cap	17.93B
Revenue (ttm)	10.59B
Net Income (ttm)	2.41B
Shares Out	3.50B
EPS (ttm)	0.69
PE Ratio	7.43
Forward PE	9.27
Dividend	0.26 (5.17%)
Ex-Dividend Date	Jun 6, 2024

Volume	5,882,000
Average Volume	5,159,978
Open	5.03
Previous Close	5.03
Day's Range	5.03 - 5.26
52-Week Range	3.35 - 5.62
Beta	0.71
RSI	63.37
Earnings Date	Mar 19, 2025

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 10,534
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0512

Financial Performance

In 2023, HKG:0512's revenue was 10.53 billion, an increase of 10.12% compared to the previous year's 9.56 billion. Earnings were 1.88 billion, a decrease of -9.59%.